Product Information
CORLANOR 7.5 MG TABLET is a brand product labeled by Amgen Inc., priced at $10.0275 per EA under NDC 55513081060. Its NADAC has been published 531 times since Sep 21, 2016.
FDA first approved this application on Apr 15, 2015.
The High Outlier badge above means this manufacturer's average price in the ivabradine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
7.5 mg/1
Manufacturer
Amgen Inc.NDC
55513081060
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
IVABRADINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA206143FDA Approved
4/15/2015
On Market Since
4/20/2015
Pharmacological Classes
Price Statistics
The NADAC for CORLANOR 7.5 MG TABLET has been published 531 times since Sep 21, 2016, and over the history we have for it it has risen 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0275 per EA |
|---|---|
| All-time high | $10.0275 (Nov 18, 2026) |
| All-time low | $6.2258 (Sep 21, 2016) |
| 52-week high | $10.0275 |
| 52-week low | $9.9839 |
| Median price | $7.9354 |
| Average price | $8.2251 |
| Largest weekly change | +5.9% (Feb 3, 2021) |
| Weeks tracked | 531 |
| Tracking since | Sep 21, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amgen Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ivabradine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CORLANOR 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CORLANOR 7.5 MG TABLET, manufactured by Amgen Inc., is $10.0275 per EA (NDC 55513081060), effective Nov 18, 2026.
How has the price of CORLANOR 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CORLANOR 7.5 MG TABLET has risen 61.1%. It has been tracked across 531 weekly CMS publications since Sep 21, 2016.
What are the highest and lowest recorded NADAC prices for CORLANOR 7.5 MG TABLET?
Since Sep 21, 2016, the NADAC for CORLANOR 7.5 MG TABLET has ranged from a low of $6.2258 (Sep 21, 2016) to a high of $10.0275 (Nov 18, 2026), with a median of $7.9354 per EA.
Are there cheaper alternatives to CORLANOR 7.5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IVABRADINE HCL 7.5 MG TABLET, is $0.6695 per EA — about 93% below CORLANOR 7.5 MG TABLET.
Who manufactures CORLANOR 7.5 MG TABLET?
CORLANOR 7.5 MG TABLET (NDC 55513081060) is labeled by Amgen Inc., and CMS classifies it as a brand product.